Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study
Segui et al.
J Psychopharmacol 2010;24:1201-1207.
ABSTRACT
Authors' reply
Palaniyappan et al.
Adv. Psychiatr. Treat. 2010;16:78-80.
FULL TEXT
Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis
van den Broek et al.
J Psychopharmacol 2009;23:708-713.
ABSTRACT
Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor
Westanmo et al.
Am J Health Syst Pharm 2005;62:2481-2490.
ABSTRACT
| FULL TEXT
Maternal Fluoxetine Treatment in the Postpartum Period: Effects on Platelet Serotonin and Plasma Drug Levels in Breastfeeding Mother-Infant Pairs
Epperson et al.
Pediatrics 2003;112:e425-e425.
ABSTRACT
| FULL TEXT
Treatment and Prevention of Depression
Hollon et al.
Psychological Science in the Public Interest 2002;3:39-77.
ABSTRACT
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study
Beyer et al.
J Psychopharmacol 2002;16:297-304.
ABSTRACT
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis
SMITH et al.
Br. J. Psychiatry 2002;180:396-404.
ABSTRACT
| FULL TEXT
Strategies for Treatment Refractory Depression
Goren
Journal of Pharmacy Practice 2001;14:478-487.
ABSTRACT
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis
FREEMANTLE et al.
Br. J. Psychiatry 2000;177:292-302.
ABSTRACT
| FULL TEXT
Evidence of the Dual Mechanisms of Action of Venlafaxine
Harvey et al.
Arch Gen Psychiatry 2000;57:503-509.
ABSTRACT
| FULL TEXT
In Vivo Chronoamperometric Measures of Extracellular Serotonin Clearance in Rat Dorsal Hippocampus: Contribution of Serotonin and Norepinephrine Transporters
Daws et al.
J. Pharmacol. Exp. Ther. 1998;286:967-976.
ABSTRACT
| FULL TEXT
Electrophysiological Characterization of the Effect of Long-Term Duloxetine Administration on the Rat Serotonergic and Noradrenergic Systems
Rueter et al.
J. Pharmacol. Exp. Ther. 1998;285:404-412.
ABSTRACT
| FULL TEXT
A Review of the Use of Augmentation Therapy for the Treatment of Resistant Depression: Implications for the Clinician
Schweitzer et al.
Aust N Z J Psychiatry 1997;31:340-352.
ABSTRACT
A 47-Year-Old Man With Chronic Depression
Goodwin
JAMA 1996;275:479-485.
ABSTRACT
Pindolol, 5-Hydroxytryptamine, and Antidepressant Augmentation
Artigas
Arch Gen Psychiatry 1995;52:969-971.
ABSTRACT
Biochemical Effects of Antidepressant Augmentation
Howland
Arch Gen Psychiatry 1995;52:156-156.
ABSTRACT
Venlafaxine: the yin and yang of antidepressants?
Nutt
J Psychopharmacol 1995;9:205-206.
Fluoxetine-Nortriptyline Therapy of Treatment-Resistant Major Depression in a Geriatric Patient
Rothschild
J Geriatr Psychiatry Neurol 1994;7:137-138.
ABSTRACT
The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants
Anderson and Tomenson
J Psychopharmacol 1994;8:238-249.
ABSTRACT
Correspondence
Aust N Z J Psychiatry 1993;27:157-168.
Fluoxetine Inhibits Desipramine Metabolism
Wilens et al.
Arch Gen Psychiatry 1992;49:752-752.
ABSTRACT
